# Larazotide for celiac disease: meta-analysis of trials

Source: https://pepvault.app/research/larazotide-hoilat-2022

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Larazotide](https://pepvault.app/research#larazotide)

Meta-analysis · people

# Larazotide: eased GI symptoms in celiac patients on gluten challenge

Checked against the paper November 2026 Meta-analysis [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In pooled trials, larazotide was generally well tolerated and helped gut symptoms mainly when celiac patients were eating gluten, with no clear change in gut permeability.

- **Kind:** Meta-analysis
- **Studied in:** People
- **Number studied:** 626
- **Published:** 2022
- **Journal:** Clin Res Hepatol Gastroenterol

## What they tested

The team set out to pool every randomized trial of larazotide in people with celiac disease to see how well it works and how safe it is.

## How the study was done

A systematic review and meta-analysis of randomized, placebo-controlled trials with 626 patients with celiac disease, 465 on larazotide and 161 on placebo (a dummy treatment). Some trials tested patients during a gluten challenge (eating 2.4-2.7 grams of gluten a day), and others tested patients on a gluten-free diet.

<!--promo-->

PepVault for iPhone

## Taking larazotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

The lactulose-to-mannitol ratio, a measure of gut permeability, did not change differently with larazotide than with placebo, whether or not patients were eating gluten. In patients on a gluten challenge, larazotide was linked to better symptom scores than placebo on both the total gastrointestinal symptom rating scale (GSRS) and its celiac-specific version (CD-GSRS). In patients on a gluten-free diet, neither symptom score differed from placebo. Larazotide also lowered gluten-related diarrhea during gluten challenge, and other side effects were similar between groups.

## What it doesn’t show

The pooled evidence comes from a small number of trials, with even fewer in patients on a gluten-free diet. The authors say more randomized trials are needed to confirm the results.

## The paper

Hoilat et al. Larazotide acetate for treatment of celiac disease: A systematic review and meta-analysis of randomized controlled trials. Clin Res Hepatol Gastroenterol. 2022.

- [PubMed (PMID 34339872)](https://pubmed.ncbi.nlm.nih.gov/34339872/)
- [The paper (DOI 10.1016/j.clinre.2021.101782)](https://doi.org/10.1016/j.clinre.2021.101782)

## The compound

- [Larazotide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/larazotide)
- [Larazotide dose guide](https://pepvault.app/lab/dosage/larazotide)

## With this study

### Larazotide

- [Larazotide: the full reference](https://pepvault.app/peptides/larazotide)
- [Larazotide dose guide](https://pepvault.app/lab/dosage/larazotide)

### Studies

- [Larazotide: no gut permeability rise after gluten in celiac patients](https://pepvault.app/research/larazotide-paterson-2007)
- [All 2 studies](https://pepvault.app/research#larazotide)

### Compared with

- [BPC-157 vs Larazotide](https://pepvault.app/peptides/compare/bpc-157-vs-larazotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)

## More studies on Larazotide

- [Larazotide: no gut permeability rise after gluten in celiac patients](https://pepvault.app/research/larazotide-paterson-2007) Randomized trial · people · 2007
- [Every study on Larazotide](https://pepvault.app/research#larazotide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking larazotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking larazotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Larazotide

- [Larazotide: the full reference](https://pepvault.app/peptides/larazotide)
- [Larazotide dose guide](https://pepvault.app/lab/dosage/larazotide)

### Studies

- [Larazotide: no gut permeability rise after gluten in celiac patients](https://pepvault.app/research/larazotide-paterson-2007)
- [All 2 studies](https://pepvault.app/research#larazotide)

### Compared with

- [BPC-157 vs Larazotide](https://pepvault.app/peptides/compare/bpc-157-vs-larazotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)

<!--promo-->

PepVault for iPhone

## Taking larazotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Larazotide](https://pepvault.app/research#larazotide)

## The library

- [Larazotide](https://pepvault.app/peptides/larazotide)
- [Larazotide dose guide](https://pepvault.app/lab/dosage/larazotide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
